Combating Parkinson’s disease, a common neurodegenerative disease
Parkinson’s disease (PD) is the second most prevalent neurological disease that affects middle-aged and elderly people. Motor symptoms in Parkinson’s disease are caused by the death of dopaminergic neurons in the substantia nigra. When these neurons die, the basal neuromotor circuit becomes dysregulated.
A key technique for treating Parkinson’s disease is to target a dopamine-related pathway. Overall, enhanced dopamine binding to receptors and dopamine pathway activity may be useful in reducing Parkinson’s symptoms.
